Insilico Medicine Appoints Carol Satler, MD., PhD, as Vice President of Clinical Development to advance Non-Oncology Programs (IMAGE)

InSilico Medicine

Insilico Medicine Appoints Carol Satler, MD., PhD, as Vice President of Clinical Development to advance Non-Oncology Programs

Caption

Carol Satler, M.D, PhD, is a seasoned physician executive with over 20 years of success in clinical development across high-growth, innovative companies. Her extensive career spans roles at Pfizer, Sanofi, Bayer, Takeda/Millennium, Puretech Health, and Gilead, where she led clinical development programs across drug discovery, development, and lifecycle planning. Notably, Dr. Satler also contributed towards the launch and commercialization of blockbuster drugs such as Plavix, Lipitor, Lovenox, Norvasc, Velcade, Avapro/Avalide, and Letairis, all of which have annual revenues exceeding $1 billion.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.